IDEXX Laboratories, Inc. (IDXX) Financials

IDXX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 3.4 billion 1.8 billion
March 31, 2026 3.4 billion 1.8 billion
Dec. 31, 2025 3.4 billion 1.7 billion
Sept. 30, 2025 3.4 billion 1.8 billion

IDXX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 322.5 million 17.0 million
March 31, 2026 234.3 million 16.3 million
Dec. 31, 2025 322.6 million 16.1 million
Sept. 30, 2025 371.2 million -44.1 million

IDXX Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 338.4 million
March 31, 2026 278.4 million
Dec. 31, 2025 248.2 million
Sept. 30, 2025 274.6 million

IDXX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 196.9 million 299.9 million 127.2 million
March 31, 2026 200.5 million 299.9 million 125.6 million
Dec. 31, 2025 180.1 million 476.0 million 101.2 million
Sept. 30, 2025 208.2 million 374.8 million 133.1 million

IDXX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 80.7 million
March 31, 2026 80.7 million
Dec. 31, 2025 80.7 million
Sept. 30, 2025 80.7 million

IDXX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 24.6 million 65.4 million 288.1 million 171.3 million
March 31, 2026 32.0 million 65.8 million 294.4 million 175.3 million
Dec. 31, 2025 29.4 million 66.8 million 275.7 million 167.1 million
Sept. 30, 2025 31.1 million 63.4 million 265.1 million 159.2 million

IDXX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 1.2 billion 437.5 million
March 31, 2026 1.1 billion 418.1 million
Dec. 31, 2025 1.1 billion 432.5 million
Sept. 30, 2025 1.1 billion 421.9 million

IDXX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

IDXX

Price: $518

52 week price:
500.61
769.98

Earnings Per Share: 14.26 USD

P/E Ratio: 41.14

Exchange: NMS

Sector: Healthcare

Industry: Diagnostics & Research

Country: United States

Volume: 353885

Ebitda: 120.9 million

Market Capitalization: 41.6 billion

Links: